Traumatic spinal cord injury (TSCI) is a devastating condition that can cause paralysis, sensory loss, and other serious complications. One new treatment option for TSCI is Stemirac. Stemirac is an autologous mesenchymal stem cell (MSC) therapy, conditionally approved by PMDA, Japan. Stemirac stem cell therapy presents hope for TSCI patients to improve their quality of … Continue reading Stemirac®: A Promising Stem Cell Therapy for Spinal Cord Injury